Analysis | Samples | Factors | Units |
---|---|---|---|
ESI Positive mode | Lamba_AML193_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Positive mode | Lamba_HL60_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Positive mode | Lamba_Kasumi1_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Positive mode | Lamba_KG1_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Positive mode | Lamba_ME1_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Positive mode | Lamba_MOLM16_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Positive mode | Lamba_MV-411_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Positive mode | Lamba_THP1_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Positive mode | Lamba_AML193_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Positive mode | Lamba_HL60_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Positive mode | Lamba_Kasumi1_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Positive mode | Lamba_KG1_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Positive mode | Lamba_ME1_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Positive mode | Lamba_MOLM16_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Positive mode | Lamba_MV-411_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Positive mode | Lamba_THP1_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Positive mode | Lamba_AML193_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Positive mode | Lamba_HL60_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Positive mode | Lamba_Kasumi1_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Positive mode | Lamba_KG1_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Positive mode | Lamba_ME1_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Positive mode | Lamba_MOLM16_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Positive mode | Lamba_MV-411_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Positive mode | Lamba_THP1_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Negative mode | Lamba_AML193_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Negative mode | Lamba_HL60_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Negative mode | Lamba_Kasumi1_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Negative mode | Lamba_KG1_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Negative mode | Lamba_ME1_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Negative mode | Lamba_MOLM16_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Negative mode | Lamba_MV-411_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Negative mode | Lamba_THP1_1 | Cytarabin Treatment (uM):0 | Peak area |
ESI Negative mode | Lamba_AML193_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Negative mode | Lamba_HL60_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Negative mode | Lamba_Kasumi1_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Negative mode | Lamba_KG1_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Negative mode | Lamba_ME1_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Negative mode | Lamba_MOLM16_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Negative mode | Lamba_MV-411_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Negative mode | Lamba_THP1_2 | Cytarabin Treatment (uM):1 | Peak area |
ESI Negative mode | Lamba_AML193_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Negative mode | Lamba_HL60_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Negative mode | Lamba_Kasumi1_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Negative mode | Lamba_KG1_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Negative mode | Lamba_ME1_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Negative mode | Lamba_MOLM16_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Negative mode | Lamba_MV-411_3 | Cytarabin Treatment (uM):10 | Peak area |
ESI Negative mode | Lamba_THP1_3 | Cytarabin Treatment (uM):10 | Peak area |